- In Alzheimer’s disease, the most common form of dementia, the blood-brain barrier is disrupted.
- A new study has uncovered unique molecular signatures linked to the disruption of this blood-brain barrier in Alzheimer’s disease.
- These findings could lead to new ways of using biomarkers in the diagnosis and treatment of this increasingly common disease.
Dementia currently affects more than
Read the full article here